Health
Regeneron suspends Covid-19 antibody trial among sickest patients – Macau Business
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients who require high-flow oxygen or are on ventilators.
The move follows a recommendation from an independent data monitoring committee (IDMC) which assesses the results and advises when it’s necessary to halt a study.
“Based on a potential safety signal and an unfavorable risk/benefit profile at this time, the IDMC recommends further enrollment of patients…
-
Noosa News23 hours agoMan shot in the leg during attempted break-in at Beenleigh, Queensland
-
Noosa News14 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
General15 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business20 hours agoDown 20% this year, here are 3 reasons why I’m still loading up on Amazon stock